Identified patient risk factors encompass female sex, the presence of diabetes mellitus, compromised baseline renal function, and the administration of angiotensin II receptor blockers (ARBs) or angiotensin-converting enzyme (ACE) inhibitors [5,6]. Here, ACE is linked to diabetes mellitus.